Diversity of circulating tumor cells in peripheral blood: Detection of heterogeneous BRAF mutations in a patient with advanced melanoma by single-cell analysis
- 1 May 2018
- journal article
- letter
- Published by Elsevier in Journal of Dermatological Science
- Vol. 90 (2) , 211-213
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (16K10149)
This publication has 10 references indexed in Scilit:
- Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 monthsExperimental Hematology & Oncology, 2017
- SnapShot: Circulating Tumor CellsCell, 2017
- Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanomaPigment Cell & Melanoma Research, 2016
- Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCRClinical Biochemistry, 2015
- Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to TreatmentJournal of Investigative Dermatology, 2015
- High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral BloodPLOS ONE, 2015
- BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK InhibitorsCancer Discovery, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Phospho-ERK Staining Is a Poor Indicator of the Mutational Status of BRAF and NRAS in Human MelanomaJournal of Investigative Dermatology, 2008
- Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosisMolecular Human Reproduction, 2003